Ganpati Exim Inc — Semaglutide Exporter Profile
Indian Pharmaceutical Exporter · #8 for Semaglutide · $148.9K export value · DGFT Verified
Ganpati Exim Inc is the #8 Indian exporter of Semaglutide with $148.9K in export value and 11 verified shipments. Ganpati Exim Inc holds a 3.0% market share in Semaglutide exports across 1 countries. The company exports 5 pharmaceutical products worth $695.3K across 3 therapeutic categories.
Ganpati Exim Inc — Semaglutide Export Profile: Buyers & Destinations
Where Does India Export Semaglutide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MAURITIUS | $1.2M | 300 | 26.8% |
| HONG KONG | $853.1K | 103 | 18.4% |
| THAILAND | $828.9K | 34 | 17.9% |
| LAOS | $318.5K | 16 | 6.9% |
| UNITED ARAB EMIRATES | $238.0K | 520 | 5.1% |
| BELGIUM | $237.6K | 441 | 5.1% |
| BOTSWANA | $200.0K | 4 | 4.3% |
| SINGAPORE | $192.2K | 277 | 4.1% |
| TAIWAN | $182.0K | 47 | 3.9% |
| CAMBODIA | $96.5K | 2 | 2.1% |
India exports Semaglutide to 69 countries. The top destination is MAURITIUS (26.8%), followed by HONG KONG and THAILAND.
Who Are the Top Buyers of Semaglutide from India?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZAPATERO INTERNATIONAL LTD | MAURITIUS | $534.4K | 59 |
| STR INTERNATIONAL TRADING CO., LTD | THAILAND | $376.9K | 22 |
| REGENCY PHARMA LIMITED | MAURITIUS | $373.0K | 120 |
| STR INTERNATIONAL TRADING CO., LIMITED | THAILAND | $300.0K | 6 |
| ZAPATERO INTERNATIONAL LIMITED | MAURITIUS | $240.2K | 26 |
| EMIRATES POST COMPANY | UNITED ARAB EMIRATES | $216.1K | 409 |
| MAXIM PHARMACY | HONG KONG | $209.0K | 9 |
| TO THE- | TAIWAN | $207.7K | 24 |
| BPOST INTERNATIONAL | BELGIUM | $163.1K | 331 |
| CALMETTE HOSPITAL | CAMBODIA | $96.5K | 2 |
India's Semaglutide is purchased by 255 buyers worldwide. The top buyer is ZAPATERO INTERNATIONAL LTD (MAURITIUS), followed by STR INTERNATIONAL TRADING CO., LTD and REGENCY PHARMA LIMITED.
What Is India's Total Semaglutide Export Value and How Much Does Ganpati Exim Inc Contribute?
India exported $4.1M worth of Semaglutide through 2,503 shipments from 140 suppliers to 69 countries, serving 255 buyers globally. Ganpati Exim Inc contributes $148.9K to this total, accounting for 3.0% of India's Semaglutide exports.
What Is the Average Shipment Value for Ganpati Exim Inc's Semaglutide Exports?
Ganpati Exim Inc's average Semaglutide shipment value is $13.5K per consignment, based on 11 shipments totaling $148.9K.
How Does Ganpati Exim Inc Compare to Other Indian Semaglutide Exporters?
Ganpati Exim Inc ranks #8 among 140 Indian Semaglutide exporters with a 3.0% market share. The top 3 exporters are KARDI TRADING PRIVATE LIMITED ($1.2M), PLEASANT EXPORTS ($814.8K), LOTUS INTERNATIONAL ($361.5K). Ganpati Exim Inc processed 11 shipments to 1 destination countries.
How Does Ganpati Exim Inc Compare to Nearest Semaglutide Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | HEXA HEALTHCARE PVT LTD | $214.3K | 18 | 1 | $11.9K |
| 5 | PRECISE BIOPHARMA PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
| 8 | GANPATI EXIM INC ★ | $148.9K | 11 | 1 | $13.5K |
| 9 | SAVA HEALTHCARE LIMITED | $117.4K | 60 | 1 | $2.0K |
| 10 | VINAYAK PHARMA CORP | $114.4K | 26 | 1 | $4.4K |
Ganpati Exim Inc ranks #8 among 140 Indian Semaglutide exporters. Average shipment value of $13.5K compared to the market average of $29.3K. The closest competitors by value are HEXA HEALTHCARE PVT LTD and PRECISE BIOPHARMA PRIVATE LIMITED.
Which Indian Ports Ship Semaglutide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,021 | 40.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 463 | 18.5% |
| HYDERABAD ACC (INHYD4) | 143 | 5.7% |
| Bombay Air | 140 | 5.6% |
| DELHI AIR | 117 | 4.7% |
| DELHI AIR CARGO ACC (INDEL4) | 87 | 3.5% |
| HYDERABAD AIR | 72 | 2.9% |
| AHEMDABAD AIR ACC (INAMD4) | 67 | 2.7% |
What Other Advanced Diabetes Medications Products Does Ganpati Exim Inc Export?
Ganpati Exim Inc also exports these advanced diabetes medications products. Each links to the detailed product page.
About Ganpati Exim Inc
Ganpati Exim Inc exports 5 products worth $695.3K. Beyond Semaglutide, top products include Canagliflozin, Empagliflozin, Linagliptin, Ivermectin. View the complete Ganpati Exim Inc profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Semaglutide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Semaglutide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ganpati Exim Inc matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 69+ countries, 255+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Semaglutide Export Data from Ganpati Exim Inc
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ganpati Exim Inc's Semaglutide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ganpati Exim Inc
Full Company Profile →
5 products · $695.3K total trade · 3 categories
Semaglutide Stats
Company Overview
Top Products by Ganpati Exim Inc
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ganpati Exim Inc.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Semaglutide. For current shipment-level data, contact TransData Nexus.